Neuroimage Biomarker Identification of the Conversion of Mild Cognitive Impairment to Alzheimer’s Disease

An efficient method to identify whether mild cognitive impairment (MCI) has progressed to Alzheimer’s disease (AD) will be beneficial to patient care. Previous studies have shown that magnetic resonance imaging (MRI) has enabled the assessment of AD progression based on imaging findings. The present...

Descripción completa

Detalles Bibliográficos
Autores principales: Kung, Te-Han, Chao, Tzu-Cheng, Xie, Yi-Ru, Pai, Ming-Chyi, Kuo, Yu-Min, Lee, Gwo Giun Chris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968420/
https://www.ncbi.nlm.nih.gov/pubmed/33746695
http://dx.doi.org/10.3389/fnins.2021.584641

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968420/
https://www.ncbi.nlm.nih.gov/pubmed/33746695
http://dx.doi.org/10.3389/fnins.2021.584641

Ejemplares similares